Replimune Group Inc (NASDAQ:REPL)

17.28
Delayed Data
As of Sep 30
 +0.66 / +3.97%
Today’s Change
13.05
Today|||52-Week Range
35.93
-36.24%
Year-to-Date
No recent news for Replimune Group Inc.

Today’s Trading

Previous close16.62
Today’s open16.78
Day’s range16.37 - 17.52
Volume8,463
Average volume (3 months)260,899
Market cap$851.0M
Data as of 4:02pm ET, 09/30/2022

Growth & Valuation

Earnings growth (last year)-29.29%
Earnings growth (this year)-36.73%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book1.99

Competitors

 Today’s
change
Today’s
% change
EDITEditas Medicine Inc+0.08+0.66%
QUREUniqure NV+0.86+4.80%
GERNGeron Corp+0.04+1.73%
MCRBSeres Therapeutics I...+0.30+4.89%
Data as of 4:02pm ET, 09/30/2022

Financials

Next reporting dateNovember 3, 2022
EPS forecast (this quarter)-$0.75
Annual revenue (last year)$0.00
Annual profit (last year)-$118.0M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
Woburn, Massachusetts

Forecasts